Bullish Case: NEWT sits at $11.18, ~1.5x book with depressed multiples; a +2.91% Helium AI drift, flat term structure, and the historical-return surface's concentration around small moves support mean reversion toward $12-13. If Q3 provisions stabilize and securitization timing normalizes, the low-IV shelf near 11-13 could rerate modestly into year-end.

Bearish Case: The stock is down 26% in sixty days and 7.7% in a month with 1337% put-volume dominance—hedging demand is surging. The Helium uncertainty distribution puts far more mass at $10 and $7.50 (0.47/0.48 density) than the market's, implying downside-skew conviction. Deep-OTM put IVs of 200-400% signal persistent crash pricing; SBA credit or securitization disappointment could extend the slide.

Potential Outcomes:

1. 40% Continued drift to $9.50-11: momentum plus put skew persists; falsified if Q3 guidance restores and securitizations close.
2. 30% Mean reversion to $11.50-13: falsified by a close below $10.50.
3. 15% Sharp bear leg to $7.50-9 on credit/liquidity shock—consistent with Helium's heavy $7.50-10 density mass.
4. 10% Recovery to $13-15 on EPS beat/buyback.
5. 5% Strategic action (M&A/bid) above $15.

Note: Helium's -0.2 forecast correlation argues against over-trusting the +2.91% signal.

October 03, 2026